are pathetic people—don't play with us."in the 1965 cbs documentary, the story of arthur king, a man experiencing alcoholism and being treated with lsd and psychotherapy, was highlighted. some of the alcoholic patients who underwent lsd and psychotherapy treatment at spring grove felt happier after the treatment and had no more desire to drink. one patient, arthur king, was admitted into spring grove state hospital as an alcoholic. he underwent the treatment. afterwards, he reported that he had no more desire to drink—he went back to school and later became an accountant. years later when he was interviewed, he said that the lsd treatment turned his life around. in an interview conducted by richard yensen, arthur king stated the following concerning treatment: "there were times when you were very emotional. yes. that was connected with what was...very unhappy…very! …thinking about things in the past and very unhappy. very, very miserable! but then i came to that point everything cleared up... it was like a peace. it was so strange."the peak experience was defined by the following guidelines1) unity-the sense that "all is one."2) transcendence of the time-space boundaries associated with ordinary reality.3) deeply felt positive mood.4) the sense that this experience is ultimately true or more real than real.5) an experience that the opposites of daily life, rather than conflictual, become instead complementary, two sides of the same coin.6) a sense or feeling of sacredness or of the preciousness of a feeling that the experience is beyond words.7) the experience is transitory.8) though transitory the experience has profound positive effects in the life of the person having it and is unforgettable shortcomings the first shortcoming determined early on in experimentation was that no adequate control group could be defined. this occludes the value of the results, and makes it difficult to deduce whether findings in the experiment were due lsd administration or simply just results of intense therapy following the drug administration. another issue was the inability to conduct the experiment utilizing the blind double-blind procedure. an additional strong criticism of the experiments was that non-drug effects on the subjects were largely underestimated, and the effects of the lsd were possibly overestimated. although the overall outcome of the treatment in the spring grove experiments was generally positive, there were also negative effects of lsd treatment in the patient including intense fear, uncontrollable breakdowns, and emotional stress during treatment. lsd was also known to produce feelings of depression, headache, and depersonalization in some cases. in addition, since subjects received lsd treatment and psychotherapy treatment, it is unclear whether the lsd caused the positive outcomes, the psychotherapy, or the carefully prepared combination of lsd and psychotherapy treatment. these shortcomings demonstrate the possibility that beneficial results in the experiments may not be attributed solely to lsd treatment. rather, it may be more likely that results occurred out of combination of the effects of social setting, therapy, and drug administration. controversy and resistance resistance from the scientific community to psychedelic therapy is thought to have resulted from certain restrictive paradigms about how studies in psychiatry and psychology should be carried out, and which ones are valid. the existing concept supported single solutions to mental health issues, and prescribing pharmaceutical drugs to biologically suppress symptoms of diseases rather than root causes. this focus on pharmaceuticals existed partially because the large amounts of government funding given to pharmaceutical companies. controversy on the use of psychedelics as medical treatment was particularly significant considering this time period (1970) constituted the early stages of the declared "war on drugs." this, along with sensationalized negative lsd cases disseminated by the media, led to a declined attitude toward the usage of lsd as treatment. other factors such as the accusation that scientists were mismanaging money, and the concern of lsd causing chromosome damage in 1969 led to further negative attitudes toward the study. termination the studies at spring grove state hospital ended in 1976. several factors led to the termination of the spring grove experiment. in 1971 walter pahnke, the director of clinical science and leader of the spring grove research team at the time, died. his successor had no background in psychedelic research and therefore did not have the experience or drive to continue the experimentation being led by pahnke before he died. the maryland psychiatric research center was accused of improper use of public money and not engaging in real treatment that would be beneficial to the public. when legislation was passed resulting in the detraction of funding from state hospitals, animosity grew between the more privileged researchers and the hospital employees. this discouraged workers from getting involved in experiments, adding to the growing negative atmosphere around lsd research. in addition, controversy surrounding the use of lsd in experiments surfaced. among these controversies include reports of a suicide in project mkultra and treatment with lsd without informed consent at edgewood arsenal in the late 1970s. because the arsenal had ties to the university of maryland, there was dramatic pressure to discontinue all research involving psychedelics as treatment. the accumulation of these reports, along with general reservations about medicalizing what the media portrayed as strictly deleterious, led to the termination of the psychedelic experiments on human subjects at spring grove. legacy by 1976, more than 700 patients were treated with psychedelic drugs. this produced positive yet equivocal results. most benefitted, and a minority did not display any response, however, there is no awareness of long-term complications. by the 1970s, lsd was no longer recognized as having a medical use. it was instead seen as having a great potential for abuse and addiction. in the 1990s, even when dr. yensen and dr. kurland received fda approval to continue lsd research, they were unable to acquire the lsd for clinical study in the united states. today, lsd research is gradually re-emerging as a focus for clinical researchers. in 2014, there was a study on the effects of lsd and psychotherapy on patients experiencing anxiety. in 2013, studies were being done on patients experiencing post traumatic stress disorder combining mdma and psychotherapy; and in 2016, an article was released announcing the fda's approval of clinical studies supporting further experiments to devise a drug for treatment of ptsd. dr. kurland's initial hopes to produce "effective therapies that will heal – more quickly and comfortably – the psychic wounds that leave so many people handicapped and alienated" remain.